Clincosm LogoSign in Get a demo

Prostatic Hyperplasia

Showing 26 - 50 of 126
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostatic Hyperplasia Trial (tamsulosin (Astellas), Tamsulosin HCL)

Completed
Has Results
  • Prostatic Hyperplasia
  • tamsulosin (Astellas)
  • Tamsulosin HCL
  • (no location specified)
Apr 15, 2020

Prostatic Hyperplasia Trial in United States (Polyphenon E, Placebo)

Completed
Has Results
  • Prostatic Hyperplasia
  • Polyphenon E
  • Placebo
  • Gainesville, Florida
  • +9 more
Oct 2, 2019

Prostate Cancer, Prostatic Hyperplasia Trial in Hong Kong (Prostate Biopsy)

Unknown status
  • Prostate Cancer
  • Prostatic Hyperplasia
  • Prostate Biopsy
  • Hong Kong, Hong Kong
    Division of Urology, Department of Surgery, Queen Mary Hospital
Sep 27, 2019

Benign Prostatic Hyperplasia and Glycosaminoglycan

Unknown status
  • Prostatic Hyperplasia
  • Urinary Glycosaminoglycan
  • Istanbul, Turkey
    Marmara University
May 20, 2019

Prostatic Hyperplasia, Benign Prostatic Hyperplasia (BPH), Prostatism Trial in Charlottesville (Embozene Microspheres)

Unknown status
  • Prostatic Hyperplasia
  • +7 more
  • Embozene Microspheres
  • Charlottesville, Virginia
    University of Virginia Health Systems
Apr 15, 2019

Prostatic Hyperplasia Trial in Worldwide (Dutasteride 0.5mg capsules, Dutasteride capsules, Tamsulosin 0.2mg tablets)

Completed
Has Results
  • Prostatic Hyperplasia
  • Dutasteride 0.5mg capsules
  • +3 more
  • Xiame, Fujian, China
  • +45 more
Jan 8, 2019

Satisfaction of Patients Operated forMild Hyperplasie of

Withdrawn
  • Prostatic Hyperplasia
  • laser surgery
  • (no location specified)
Feb 1, 2019

Prostatic Hyperplasia Trial in Worldwide (Tamsulosin, UK-369,003)

Completed
  • Prostatic Hyperplasia
  • Herston, Queensland, Australia
  • +45 more
Dec 16, 2018

Prostatic Hyperplasia Trial in Fort Lauderdale (Embosphere Microspheres)

Terminated
Has Results
  • Prostatic Hyperplasia
  • Embosphere Microspheres
  • Fort Lauderdale, Florida
    Holy Cross Hospital
Oct 9, 2018

Metabolic Parameters and Urinary Symptoms in Bariatric Patients

Completed
  • Obesity
  • +3 more
    • Florence, Italy
      Ambulatori Medicina della Sessualità e Andrologia
    Oct 11, 2018

    Prostatic Hyperplasia, Prostatic Hypertrophy, Benign Trial in United States (Doxazosin, Finasteride, Doxazosin )

    Completed
    • Prostatic Hyperplasia
    • Prostatic Hypertrophy, Benign
    • La Jolla, California
    • +16 more
    Sep 26, 2018

    Prostatic Hyperplasia Trial in Japan (Dutasteride, Placebo)

    Completed
    Has Results
    • Prostatic Hyperplasia
    • Chiba, Japan
    • +25 more
    Aug 30, 2018

    Prostatic Hyperplasia Trial in Worldwide (Dutasteride plus tamsulosin, Placebo)

    Completed
    Has Results
    • Prostatic Hyperplasia
    • Dutasteride plus tamsulosin
    • Placebo
    • Randwick, New South Wales, Australia
    • +66 more
    Jul 20, 2018

    Prostatic Hyperplasia Trial in Ho Chi Minh (Dutasteride/Tamsulosin)

    Terminated
    Has Results
    • Prostatic Hyperplasia
    • Ho Chi Minh, Vietnam
      GSK Investigational Site
    Jul 20, 2018

    Prostatic Hyperplasia Trial in Worldwide (Dutasteride plus tamsulosin, tamsulosin)

    Completed
    Has Results
    • Prostatic Hyperplasia
    • Aigrefeuille Sur Maine, France
    • +79 more
    Jul 20, 2018

    Ejaculation Abnormal, BPH With Urinary Obstruction, Prostatic Hyperplasia Trial in Mansourah (Ejaculation Preserving

    Unknown status
    • Ejaculation Abnormal
    • +4 more
    • Ejaculation Preserving Photoselective Vaporization
    • +2 more
    • Mansourah, Egypt
      Urology & Nephrology Center
    Jul 4, 2018

    Prostatic Hyperplasia Trial in Fukuoka (Dutasteride-Test product, Dutasteride-Reference product)

    Completed
    • Prostatic Hyperplasia
    • Dutasteride-Test product
    • Dutasteride-Reference product
    • Fukuoka, Japan
      GSK Investigational Site
    Jun 18, 2018

    Prostatic Hyperplasia Trial in Austin (dutasteride)

    Completed
    • Prostatic Hyperplasia
    • Austin, Texas
      GSK Investigational Site
    Jun 18, 2018

    Prostatic Hyperplasia Trial in Baltimore (Treatment sequence A, Treatment sequence B, Treatment sequence C)

    Completed
    • Prostatic Hyperplasia
    • Treatment sequence A
    • +2 more
    • Baltimore, Maryland
      GSK Investigational Site
    Jun 18, 2018

    Prostatic Hyperplasia Trial in Shanghai (Dutasteride and Tamsulosin)

    Completed
    • Prostatic Hyperplasia
    • Dutasteride and Tamsulosin
    • Shanghai, China
      GSK Investigational Site
    Jun 18, 2018

    Prostatic Hyperplasia Trial in Randwick (Dutasteride (0.5mg, fasted state), Dutasteride (0.5mg, fed state), Fixed dose

    Completed
    • Prostatic Hyperplasia
    • Dutasteride (0.5mg, fasted state)
    • +6 more
    • Randwick, New South Wales, Australia
      GSK Investigational Site
    Jun 18, 2018

    Prostatic Hyperplasia Trial in Randwick (Dutasteride (0.5mg), FDC product of dutasteride (0.5mg) and tamsulosin HCl (0.2mg),

    Completed
    • Prostatic Hyperplasia
    • Dutasteride (0.5mg)
    • +2 more
    • Randwick, New South Wales, Australia
      GSK Investigational Site
    Jun 18, 2018

    Prostatic Hyperplasia Trial in Baltimore (FDC capsule of dutasteride and tamsulosin, Dutasteride soft gelatine capsule and

    Completed
    • Prostatic Hyperplasia
    • FDC capsule of dutasteride and tamsulosin
    • Dutasteride soft gelatine capsule and tamsulosin HCl oral disintegrating tablet
    • Baltimore, Maryland
      GSK Investigational Site
    Jun 18, 2018

    Prostatic Hyperplasia Trial in Mansoura (Low power Holmium laser enucleation of the prostate, High power Holmium laser

    Completed
    • Prostatic Hyperplasia
    • Low power Holmium laser enucleation of the prostate
    • High power Holmium laser enucleation of the prostate
    • Mansoura, DK, Egypt
      Urology and nephrology center
    Mar 31, 2018

    Male, Ultrasonography, Botulinum Toxins, Type A Trial in Cairo (Botulinum toxin A, Ethanol)

    Completed
    • Male
    • +4 more
    • Botulinum toxin A
    • Ethanol
    • Cairo, Egypt
      Cairo University Hospitals
    Dec 27, 2017